{
  "ptid_time": "002_S_4262_2013-11-06",
  "img_path": "/data/qiuhui/data/adni/images/002_S_4262/2013-11-06/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 73,249 mm³, 161.0% above the reference mean. With a Z-score of 3.69 (100.0th percentile), this represents profound enlargement; hippocampal volume measures 6,940 mm³, 2.5% below the reference mean. With a Z-score of -0.23 (41.1th percentile), this represents normal volume ; whole brain volume measures 938,627 mm³, 3.7% below the reference mean. With a Z-score of -0.47 (32.1th percentile), this represents normal volume . ",
  "text_data": "Age is 74.8 years. Gender is Female. Education: 16 years. MMSE: 27.0. MoCA: 28.0. Logical Memory: 14.0. APOEε4 alleles: 0.0. Biomarker levels: Florbetapir (AV45): 1.42 SUVR (significant elevated); Amyloid beta: 848.40 pg/mL (normal ); Total tau: 408.50 pg/mL (significant elevated); Phosphorylated tau: 40.18 pg/mL (significant elevated). ",
  "true_diagnosis": "Diagnosis: MCI.",
  "gpt_diagnosis": "**Reasoning:** The data shows profound ventricular enlargement (Z-score 3.69) with normal hippocampal and whole brain volumes, suggesting possible neurodegenerative changes. Elevated T-tau, P-tau, and AV45 (amyloid PET) indicate Alzheimer's pathology, but cognitive scores (MMSE 27, MoCA 28) remain intact.  \n\n**Diagnosis:** **Mild Cognitive Impairment (MCI)** (likely due to Alzheimer's pathology, given biomarker profile).  \n**Confidence:** **Medium** (cognitive scores are borderline normal, but biomarkers strongly suggest early neurodegeneration).  \n\n*Note: The discrepancy between preserved cognition and significant biomarker abnormalities suggests either very early MCI or a resilient cognitive reserve. Follow-up monitoring is recommended.*",
  "timestamp": "2025-07-25T20:26:09.193014"
}